Radiopharm Theranostics Limited American Depositary Shares
Symbol: RADX (NASDAQ)
5.76
▲ (6.57%) 0.355
Company Description:
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.
Key Stats
- Today's Open: $5.5
- Today's High: $6.894
- Today's Low: $5.35
- Today's Volume: 19.38K
- Yesterday Close: $5.405
- Yesterday High: $5.9001
- Yesterday Low: $5.29
- Yesterday Volume: 33.44K
- Last Min Volume: 1
- Last Min High: $5.76
- Last Min Low: $5.76
- Last Min VWAP: $5.76
Company Profile
- Name: Radiopharm Theranostics Limited American Depositary Shares
- Website: https://www.radiopharmtheranostics.com
- Listed Date: 2024-11-27
- Location: ,
- Market Status: Active
- CIK Number: 0001949257
- SIC Code:
- SIC description:
- Market Cap: $47.15M
- Round Lot: 100
- Outstanding Shares: 7.78M
- Asset Type: ADRC
RECENT FILINGS FOR RADX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-23 | 6-K | View |
| 2025-10-20 | 6-K | View |
| 2025-10-07 | 6-K | View |
| 2025-10-01 | 6-K | View |
| 2025-09-30 | 6-K | View |
| 2025-09-18 | 20-F | View |
| 2025-09-17 | 6-K | View |
| 2025-09-15 | 6-K | View |
| 2025-08-29 | 6-K | View |
| 2025-08-21 | 6-K | View |
| 2025-08-01 | 6-K | View |
| 2025-07-29 | 6-K | View |
| 2025-07-28 | 6-K | View |
| 2025-07-23 | SCHEDULE 13G | View |
| 2025-07-22 | 6-K | View |
| 2025-07-16 | SCHEDULE 13G/A | View |
| 2025-07-16 | 6-K | View |
| 2025-06-24 | 6-K | View |
| 2025-06-12 | 6-K | View |
| 2025-06-11 | 6-K | View |